Targeted next-generation sequencing as a diagnostic tool in gastrointestinal system cancer/polyposis
dc.authorid | atli, emine ikbal/0000-0001-9003-1449 | |
dc.authorid | Gürkan, Hakan/0000-0002-8967-6124 | |
dc.authorid | Cicin, Irfan/0000-0002-7584-3868 | |
dc.authorid | EKER, DAMLA/0000-0001-7563-118X | |
dc.authorid | YALCINTEPE, Sinem/0000-0002-8557-8885 | |
dc.authorwosid | atli, emine ikbal/AAN-5060-2020 | |
dc.authorwosid | Gürkan, Hakan/AAF-2866-2020 | |
dc.authorwosid | ATLI, Engin/AAY-4641-2021 | |
dc.authorwosid | Demir, Selma/A-1500-2018 | |
dc.authorwosid | Cicin, Irfan/AAQ-5575-2020 | |
dc.contributor.author | Yalcintepe, Sinem | |
dc.contributor.author | Gurkan, Hakan | |
dc.contributor.author | Demir, Selma | |
dc.contributor.author | Tozkir, Hilmi | |
dc.contributor.author | Tezel, Huseyin Ahmet | |
dc.contributor.author | Atli, Emine Ikbal | |
dc.contributor.author | Atli, Engin | |
dc.date.accessioned | 2024-06-12T11:03:10Z | |
dc.date.available | 2024-06-12T11:03:10Z | |
dc.date.issued | 2020 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | Background: Recent advances in next-generation sequencing (NGS) technology have enabled multigene testing and changed the diagnostic approach to hereditary gastrointestinal cancer/polyposis syndromes. The aim of this study was to analyze different cancer predisposition genes in hereditary/sporadic gastrointestinal cancer/polyposis. Methods: Cancer predisposition genes were analyzed with an Illumina MiSeq NGS system in 80 patients with gastrointestinal cancer/polyposis who were examined between the years 2016 and 2019. Deletion/duplication analysis of MLH1, MSH2, and EPCAM genes was performed by using the multiplex ligation-dependent probe amplification method. Results: Germline testing of hereditary cancer-related genes was performed in 80 patients with gastrointestinal cancer/polyposis. A total of 30 variants in 30 cases (37.5%) were assessed as pathogenic/likely pathogenic. A total of 19 heterozygous variants were assessed as variants of uncertain clinical significance in 17 cases (21.25%) and 18 (22.5%) novel variations (9 pathogenic/likely pathogenic, 9 variants of uncertain significance) were determined. In 4 (5%) cases, multiplex ligation-dependent probe amplification detected deletions in MLH1, MSH2, and EPCAM genes. Conclusion: The accumulation of analyses with multigene testing will increase the available data for cancer predisposition genes in hereditary gastrointestinal cancer/polyposis. Educational campaigns for prevention, efficient screening programs, and more personalized care based on the profile of individual patients are necessary. | en_US |
dc.identifier.doi | 10.1177/0300891620919171 | |
dc.identifier.endpage | 517 | en_US |
dc.identifier.issn | 0300-8916 | |
dc.identifier.issn | 2038-2529 | |
dc.identifier.issue | 6 | en_US |
dc.identifier.pmid | 32390558 | en_US |
dc.identifier.scopus | 2-s2.0-85084825816 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 510 | en_US |
dc.identifier.uri | https://doi.org/10.1177/0300891620919171 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/21559 | |
dc.identifier.volume | 106 | en_US |
dc.identifier.wos | WOS:000535534700001 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Sage Publications Ltd | en_US |
dc.relation.ispartof | Tumori Journal | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Hereditary Colorectal Cancer | en_US |
dc.subject | Polyposis | en_US |
dc.subject | Multigene Testing | en_US |
dc.subject | Next-Generation Sequencing | en_US |
dc.subject | Genetic Counseling | en_US |
dc.subject | Cancer | en_US |
dc.subject | Hereditary | en_US |
dc.subject | Risk | en_US |
dc.subject | Epidemiology | en_US |
dc.subject | Variants | en_US |
dc.subject | Recommendations | en_US |
dc.subject | Susceptibility | en_US |
dc.subject | Challenges | en_US |
dc.subject | Polyposis | en_US |
dc.subject | Genetics | en_US |
dc.title | Targeted next-generation sequencing as a diagnostic tool in gastrointestinal system cancer/polyposis | en_US |
dc.type | Article | en_US |